References
- Bateman E D, Hurd S S, Barnes P J, Bousquet J, Drazen J M, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen S E, Pizzichini E, Sullivan S D, Wenzel S E, Zar H J. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143–178
- Rabe K F, Adachi M, Lai C K, Soriano J B, Vermeire P A, Weiss K B, Weiss S T. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114: 40–47
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2006, Available at www.ginasthma.org
- Gibson P G, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med 2001; 163: 32–36
- Rodrigo G J. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest 2006; 130: 1301–1311
- Berger W E. The use of inhaled formoterol in the treatment of asthma. Ann Allergy Asthma Immunol 2006; 97: 24–33
- O'Byrne P M, Bisgaard H, Godard P P, Pistolesi M, Palmqvist M, Zhu Y, Ekstrom T, Bateman E D. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005; 171: 129–136
- Rabe K F, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo U G. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006; 368: 744–753
- Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet L P, Naya I P, Hultquist C. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004; 20: 1403–1418
- Vogelmeier C, D'Urzo A, Pauwels R, Merino J M, Jaspal M, Boutet S, Naya I, Price D. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?. Eur Respir J 2005; 26: 819–828
- Zetterstrom O, Buhl R, Mellem H, Perpina M, Hedman J, O'Neill S, Ekstrom T. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 2001; 18: 262–268
- Balanag V M, Yunus F, Yang P C, Jorup C. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharmacol Ther 2006; 19: 139–147
- Palmqvist M, Persson G, Lazer L, Rosenborg J, Larsson P, Lotvall J. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. Eur Respir J 1997; 10: 2484–2489
- Heiner M M. Key barriers to optimal management of adult asthma in Australia: physician and patient perspectives. Curr Med Res Opin 2007; 23: 1799–1807
- Rabe K F, Vermeire P A, Soriano J B, Maier W C. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802–807
- Loh L C, Lim B K, Raman S, Vijayasingham P, Mohd Yusuf S. Budesonide/formoterol combination therapy as bothg maintenance and reliever medication in moderate-to-severe asthma: a real-life effectiveness study of Malaysian patients. Med J Malaysia 2008; 63: 188–192
- Cates C J, Lasserson T J. Combination formoterol and inhaled steroid versus beta-2-agonist as relief medication for chronic asthma in adults and children. Cochrane Database Syst rev 2009; 21, CD007085